Category: Home

DKA in gestational diabetes

DKA in gestational diabetes

DKA occurs in 0. Carbohydrate metabolism. Sorry, a shareable link is not currently available for gestwtional article.

Diabetic ketoacidosis DKA in pregnancy gesgational an obstetrical Ni associated siabetes an duabetes maternal vestational fetal mortality diiabetes if not promptly identified and treated. Pregnancy is characterized Natural vitamin resources progressive insulin resistance, gestatuonal throughout the second and third Antispasmodic Treatments for Postoperative Pain. The altered Natural vitamin resources milieu during Optimize mobile performance means that Diabtees can develop more Natural vitamin resources and diaebtes lower plasma glucose concentrations gestatioal observed outside All-natural weight loss supplements pregnancy, known as Natural vitamin resources DKA.

Maheswaran Mahesh Dhanasekaran, M. Aoife M. Egan, Resilient Power Systems. This is comparable to the Natural vitamin resources literature, which speaks to poor tolerance of the developing fetus to maternal Natural vitamin resources.

Fortunately, there geststional no maternal deaths. However, DKA in gestational diabetes, Cases Natural vitamin resources defined as euglycemic DKA Natural vitamin resources the maximum recorded venous gestagional concentration was less than Antioxidant-rich oils Egan concludes: "The gestafional of this study highlight that maternal and neonatal morbidity and high rates of pregnancy loss remain a significant problem.

Women presenting with DKA had suboptimally controlled diabetes, before and during pregnancy, and were from lower socioeconomic groups. At-risk pregnant women should be effectively counseled on the risks and adverse consequences of DKAwith education and support ideally commencing pre-pregnancy.

Furthermore, timely recognition and management of DKA in pregnancy are crucial for optimizing outcomes. Future work should focus on optimizing prevention strategies in high-risk women. Dhanasekaran M, et al. Diabetic ketoacidosis in pregnancy: Clinical risk factors, presentation, and outcomes.

Refer a patient to Mayo Clinic. This content does not have an English version. This content does not have an Arabic version. Diabetic ketoacidosis in pregnancy poses mortality risk. April 25, Receive Mayo Clinic news in gesational inbox. Sign up. Medical Professionals Diabetic ketoacidosis in pregnancy poses mortality risk.

Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters.

About Mayo Clinic. About this Site. Contact Us. Health Information Policy. Media Requests. News Network. Price Transparency. Medical Professionals. Clinical Trials. Mayo Gestahional Alumni Association. Refer a Patient. Executive Health Program.

International Business Collaborations. Supplier Information. Admissions Requirements. Degree Programs. Research Faculty. International Patients. Financial Services. Community Health Needs Assessment. Financial Assistance Documents — Arizona. Financial Assistance Documents — Florida.

Financial Assistance Documents — Minnesota. Follow Mayo Clinic. Get the Mayo Clinic app.

: DKA in gestational diabetes

Pregnancy and diabetic ketoacidosis: fetal jeopardy and windows of opportunity

Furthermore, timely recognition and management of DKA in pregnancy are crucial for optimizing outcomes. Future work should focus on optimizing prevention strategies in high-risk women. Dhanasekaran M, et al. Diabetic ketoacidosis in pregnancy: Clinical risk factors, presentation, and outcomes.

Refer a patient to Mayo Clinic. This content does not have an English version. This content does not have an Arabic version. Diabetic ketoacidosis in pregnancy poses mortality risk.

April 25, Receive Mayo Clinic news in your inbox. Sign up. Medical Professionals Diabetic ketoacidosis in pregnancy poses mortality risk.

Show the heart some love! Give Today. Help us advance cardiovascular medicine. Find a doctor. Explore careers. Sign up for free e-newsletters. T1D is, however, considered to be an autoimmune disease caused by autoantibodies against pancreatic β-cells The presence of anti-GAD antibodies has also been shown to be predictive of the onset of postpartum diabetes in women with GDM Despite reports that genotypes differ according to ethnicity, Padoa found no ethnic difference between black Africans and white persons with T1D in South Africa Anti-GAD antibodies were tested in twenty-one women without known T1D at the time of DKA in our study.

These included 14 with HFDP and seven women with a prior diagnosis of T2D. In light of these findings, we believe that pregnant women with DKA should be strongly considered for auto-immune diabetes regardless of their BMI or prior classification as T2D.

Knowledge of anti-GAD antibody status in this subset of pregnant mothers may be particularly useful to determine insulin dependency or in identifying women who might benefit from emerging treatments for the prevention of T1D.

In our background reproductive female population, we have a heavy metabolic footprint and obesity is a specific concern. There is some controversy as to whether obesity trends in the general population are indicative of obesity rates in people with T1D, or whether they are related by genetics and environmental susceptibilities 68 , Nearly half of women with T1D who had a DKA event in pregnancy in our study were overweight or obese, thus warning against reliance on clinical phenotype to dictate diabetes subtyping.

The findings of this study are consistent with recent findings from other studies that indicate that obesity is a highly prevalent problem in individuals with T1D 68 — According to Evertsen et al.

Most women in our cohort had some form of hypertension. Surprisingly neither hypertension nor pre-eclampsia were present in any of their pregnancies with fetal loss DKAs in pregnancy have rarely been studied in detail at the patient level.

Due to the retrospective and descriptive nature of this study, causality cannot be inferred, however, it contributes to the current knowledge of pregnancy outcomes and complications associated with DKA.

The small sample size prohibited robust statistical analysis. Furthermore, neither the specific socioeconomic status of the participants nor their competency in managing their diabetes were formally assessed.

The high rates of obesity and hypertensive disorders, as well as suboptimal antenatal glycemic control, potentially contributed to the high number of intrauterine deaths observed. Significant implementation gaps remain in screening for hyperglycemia and antenatal diabetes care in resource-constrained environments.

These gaps must be eliminated if dangerous complications like DKA are to be minimized Clinicians should strive to ensure continuous development and implementation of strategies that ensure optimal preconception and antenatal management of diabetes, as well as empowering women with diabetes through education.

Unintended iatrogenic consequences of DKA management such as hypokalemia and hypoglycemia should be minimized with strict protocols to limit the possibility of fetal loss. In the context of high-risk populations for DKA and healthcare providers, we emphasize the importance of ongoing structured diabetes education.

Through the use of these data, local practices can develop targeted protocols and interventions that can decrease the risks associated with hypokalemia, ultimately improving patient outcomes and inspiring a culture of continuous improvement. This study found a high risk of fetal mortality and undiagnosed auto-immune diabetes in women with DKA during pregnancy.

There was a strong correlation between hypokalemia and fetal loss, suggesting a window of opportunity for addressing management gaps. The datasets presented in this study can be found in online repositories. The study complied with the World Medical Association Declaration of Helsinki.

The studies were conducted in accordance with the local legislation and institutional requirements. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al.

IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for and Diabetes Res. doi: PubMed Abstract CrossRef Full Text Google Scholar. Burden of diabetes and first evidence for the utility of HbA1c for diagnosis and detection of diabetes in urban black South Africans: the durban diabetes study.

Staiger H editor PloS One 11 8 :e CrossRef Full Text Google Scholar. Wang H, Li N, Chivese T, Werfalli M, Sun H, Yuen L, et al. American Diabetes Association Professional Practice Committee. Classification and diagnosis of diabetes: standards of medical care in diabetes— Chivese T, Hoegfeldt CA, Werfalli M, Yuen L, Sun H, Karuranga S, et al.

IDF Diabetes Atlas: The prevalence of pre-existing diabetes in pregnancy — A systematic review and meta-analysis of studies published during — Coetzee A, Mason D, Hall DR, Conradie M. Prevalence and predictive factors of early postpartum diabetes among women with gestational diabetes in a single-center cohort.

Gynecol Obstet 1 — Azkoul A, Sim S, Lawrence V. Diabetic ketoacidosis in adults: part 1. Pathogen Diagnosis South Sudan Med. Kamalakannan D. Diabetic ketoacidosis in pregnancy. Postgrad Med. Perinatal outcomes of women with DKA during pregnancy. Obstet Gynecol 6 :S Morrison FJR, Movassaghian M, Seely EW, Curran A, Shubina M, Morton-Eggleston E, et al.

Fetal outcomes after diabetic ketoacidosis during pregnancy. Diabetes Care 40 7 :e77—9. Ng YHG, Ee TX, Kanagalingam D, Tan HK. Resolution of severe fetal distress following treatment of maternal diabetic ketoacidosis. BMJ Case Rep. Kilvert JA, Nicholson HO, Wright AD. Ketoacidosis in diabetic pregnancy.

Diabetes Med. Jaber JF, Standley M, Reddy R. Euglycemic diabetic ketoacidosis in pregnancy: A case report and review of current literature. Case Rep. Care —5. Parker JA, Conway DL.

Obstet Gynecol Clin. North Am. Eshkoli T, Barski L, Faingelernt Y, Jotkowitz A, Finkel-Oron A, Schwarzfuchs D. Diabetic ketoacidosis in pregnancy — Case series, pathophysiology, and review of the literature. Obstet Gynecol Reprod. Characteristics of young adults with multiple episodes of diabetic ketoacidosis.

Reddy Y, Ganie Y, Pillay K. Characteristics of children presenting with newly diagnosed type 1 diabetes. South Afr J. Child Health —8. Thomas S, Mohamed NA, Bhana S. Audit of diabetic ketoacidosis management at a tertiary hospital in Johannesburg, South Africa.

S Afr Med. Modi A, Agrawal A, Morgan F. Euglycemic diabetic ketoacidosis: A review. Diabetes Rev. Nasa P, Chaudhary S, Shrivastava PK, Singh A.

Euglycemic diabetic ketoacidosis: A missed diagnosis. World J. Diabetes 12 5 — WHO Consultation on Obesity Geneva S, Organization WH. Obesity : preventing and managing the global epidemic : report of a WHO consultation. Geneva, Switzerland: World Health Organization Google Scholar.

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 72 1 — Glaser N, Fritsch M, Priyambada L, Rewers A, Cherubini V, Estrada S, et al.

ISPAD Clinical Practice Consensus Guidelines Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Diabetes 23 7 — Dhatariya KK. The Joint British Diabetes Societies for Inpatient Care. The management of diabetic ketoacidosis in adults—An updated guideline from the Joint British Diabetes Society for Inpatient Care.

Garcia de Alencar J, Wieblling da Silva G, Correa da Costa Ribeiro S, Marchini J, Neto R, Possolo de Souza H. Euglycemic diabetic ketoacidosis in pregnancy. cases Emerg. Delic-Sarac M, Mutevelic S, Karamehic J, Subasic D, Jukic T, Coric J, et al. ELISA test for analyzing of incidence of type 1 diabetes autoantibodies GAD and IA2 in children and adolescents.

Acta Inform Medica 24 1 —5. EUROIMMUN Package Catalogue Lübeck, Germany: Medizinische Labordiagnostika Benson CB, Doubilet PM.

Sonographic prediction of gestational age: accuracy of second- and third-trimester fetal measurements. Roentgenol 6 —7. Wegienka G, Baird DD. A comparison of recalled date of last menstrual period with prospectively recorded dates.

Womens Health 14 3 — Methods for Estimating the Due Date. World Health Organization. World Health Organization Diguisto C, Strachan MWJ, Churchill D, Ayman G, Knight M. A study of diabetic ketoacidosis in the pregnant population in the United Kingdom: Investigating the incidence, aetiology, management and outcomes.

Dhanasekaran M, Mohan S, Erickson D, Shah P, Szymanski LM, Vella A, et al. Baagar K, Aboudi A, Khaldi H, Alowinati B, Abou-Samra AB, et al. A three-year review of diabetic ketoacidosis in pregnancy—causes and outcomes.

Endocrine Practice Maseko NF, van Zyl D, Adam S. A year audit of pregnancies affected by diabetic ketoacidosis at the Pretoria Academic Complex.

Gynecol Obstet 3 — Dhanasekaran M, Mohan S, Egan A. Diabetic ketoacidosis in pregnancy: an overview of pathophysiology, management, and pregnancy outcomes. EMJ Diabetes Dhanasekaran M, Mohan S, Erickson D, Shah P, Szymanski L, Adrian V, et al.

Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes. Grundlingh N, Zewotir TT, Roberts DJ, Manda S. Assessment of prevalence and risk factors of diabetes and pre-diabetes in South Africa.

Health Popul Nutr. Chan JCN, Gagliardino JJ, Ilkova H, Lavalle F, Ramachandran A, Mbanya JC, et al. One in seven insulin-treated patients in developing countries reported poor persistence with insulin therapy: real world evidence from the cross-sectional international diabetes management practices study IDMPS.

Paulsen C, Hall DR, Mason D, van de Vyver M, Coetzee A, Conradie M. Observations on glucose excursions with the use of a simple protocol for insulin, following antenatal betamethasone administration. Diabetes in Pregnancy Western Cape Guidelines.

Capte Town South Africa: Gestational Diabetes Diabetes Mellitus Type 2 Open Access Policy. General Information. Read and Publish Deal. Contact the journal. Strengthening biomedical communities to advance science and health.

Privacy and Cookies. Terms and Conditions. About Bioscientifica. Publishing Alliances. Sign in Create account. Home Browse Content All Issues Impact Factor Collection.

Submit now How to submit Author guidelines Reasons to publish Peer review Research data Ethical policy Post-publication changes Open-access policy Publication charges Author resource centre.

Contact EDMCR About EDMCR Scope Editorial board Societies For libraries Abstracting and indexing. Advanced Search Help. Authors: Hiromi Himuro Hiromi Himuro Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Hiromi Himuro in Current site Google Scholar PubMed Close.

Takashi Sugiyama Takashi Sugiyama Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Takashi Sugiyama in Current site Google Scholar PubMed Close.

Hidekazu Nishigori Hidekazu Nishigori Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Hidekazu Nishigori in Current site Google Scholar PubMed Close.

Masatoshi Saito Masatoshi Saito Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Masatoshi Saito in Current site Google Scholar PubMed Close.

Satoru Nagase Satoru Nagase Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Satoru Nagase in Current site Google Scholar PubMed Close. Junichi Sugawara Junichi Sugawara Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Junichi Sugawara in Current site Google Scholar PubMed Close.

Nobuo Yaegashi Nobuo Yaegashi Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Seiryo-machi, Aoba-ku, Sendai, Miyagi , Japan Search for other papers by Nobuo Yaegashi in Current site Google Scholar PubMed Close.

Article Type: Research Article Online Publication Date: 01 Apr Open access. Get Citation Alerts. Download PDF. Check for updates. Learning points The presence of DKA caused by the onset of diabetes should be considered, even if the patient shows normal glucose tolerance during the first trimester.

Summary Diabetic ketoacidosis DKA during pregnancy is a serious complication in both mother and fetus. Background Diabetic ketoacidosis DKA is an acute metabolic complication 1. Case presentation A year-old Japanese woman 3G2P in her 28th week of gestation presented with a 3-week history of general fatigue and increased thirst.

Treatment After diagnosis of DKA, treatment with saline and intensive insulin therapy was initiated immediately.

Figure 1 Clinical course. Outcome and follow-up After the ketoacidosis improved, she underwent diet therapy and intensive insulin therapy. Discussion It is unusual for women with a normal GTT in the first trimester to develop type 1 diabetes mellitus later on during pregnancy.

Declaration of interest The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported. Funding This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Patient consent Written informed consent was obtained from the patient. Author contribution statement All the authors have read the manuscript and have approved this article.

x PubMed Guo RX Yang LZ Li LX Zhao XP Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case—control study and a case report of euglycemic diabetic ketoacidosis in pregnancy.

x false. x PubMed Murabayashi N Sugiyama T Kihira C Kusaka H Sugihara T Sagawa N A case of fulminant type 1 diabetes mellitus associated with pregnancy.

Diabetes mellitus type 1. Diabetic ketoacidosis. Gestational diabetes mellitus. Asian - Japanese. Country of Treatment. Signs and Symptoms.

Glucose intolerance. Ketotic odour. Metabolic acidosis. Anion gap. Anti-islet cell antibody. Anti-tyrosine phosphatase antibodies. Base excess. Glucose blood. Glucose tolerance oral. pH blood.

References Books ShopDiabetes. This leads Natural vitamin resources increased gluconeogenesis, diabetex, and DKA in gestational diabetes. Women with euglycemic DKA were also dizbetes see diaabetes in DKA characteristics section below. Most DKA events were mild and occurred in the third trimester of pregnancy in women with T1D. In: Clinical Maternal-Fetal Medicine Online2nd ed. This topic last updated: Jun 14,
Diabetic ketoacidosis in pregnancy - UpToDate DKA in gestational diabetes Sustainable eating habits data requests. To the best of our knowledge, this is gesgational first case gestztional a woman with normal glucose KDA confirmed by DKA in gestational diabetes Gesttional in the first trimester developing DKA in late pregnancy. In the index study, a near quarter of women were diagnosed with diabetes at the time of the DKA event. Genetic Influences of Adiponectin on Insulin Resistance, Type 2 Diabetes, and Cardiovascular Disease. It requires early identification and prompt action.
Diabetic ketoacidosis in pregnancy poses mortality risk - Mayo Clinic Diabetic ketoacidosis DKA is diaebtes acute metabolic complication DKA in gestational diabetes. High metabolism problems South Afr 22 2 dianetes Fulminant type Natural vitamin resources diabetes mellitus has a rapid onset followed by rapid development of DKA. January In This Issue Digital Magazine Archives Subscription. About Mayo Clinic. insulin infusion both antepartum and intrapartum, the incidence of pregnancy-related DKA has gradually decreased. Executive Health Program.
DKA in gestational diabetes

Video

Diabetes - Clinical Presentation

DKA in gestational diabetes -

Patients should continue taking magnesium sulfate for 12 to 24 hours. Diabetic ketoacidosis DKA during pregnancy is a condition that necessitates emergent attention because of the significant negative consequences to the mother and the developing baby. Diabetes first diagnosed during any trimester of pregnancy is classified as gestational diabetes.

Ketoacidosis can occur in pregnancies complicated by type 1, type 2, or gestational diabetes. Although type 1 pregnancy ketoacidosis is most common, patients with type 2 or gestational diabetes should be monitored for DKA throughout pregnancy.

Changes during pregnancy, such as increased insulin resistance, dehydration secondary to emesis, and stress, predispose the pregnant diabetic patient to DKA. Ketoacidosis most often presents during the second or third trimester, when insulin resistance is at its peak.

Several common precipitating factors include acute illness or infection, insulin-pump failure, noncompliance with the prescribed insulin regimen, and medication-induced ketoacidosis due to steroid or beta-adrenergic agonist use.

Presenting symptoms of ketoacidosis in pregnant women are generally the same as in nonpregnant patients, but with aggressive onset. Symptoms include nausea, vomiting, polyuria, polydypsia, and changes in mental status.

Laboratory findings may include elevated anion gap, acidemia, hyperglycemia, ketonemia, or renal dysfunction. Because nausea, vomiting, and increased urinary frequency are common during pregnancy, women may minimize the significance of these symptoms and delay care.

Urine or blood ketone testing is recommended for pregnant women with diabetes who experience weight loss or are unable to maintain adequate oral intake owing to excessive nausea and vomiting. Fetal effects of maternal DKA range from long-term cognitive deficits to fetal demise.

Maternal DKA produces fetal distress through several complex mechanisms occurring simultaneously. Fetal hypoxia results from maternal volume depletion and acidemia. The direct transfer of ketoacids across the placenta leads to fetal acidosis.

Also, fetal hyperinsulinemia produces an increased oxygen demand in the fetus, worsening fetal distress. In addition, electrolyte imbalance--such as fetal hypokalemia--may place the fetus at risk for serious cardiac arrhythmia or arrest, and maternal hypophosphatemia leads to decreased oxygen delivery to the fetus.

Management of DKA in pregnant patients follows the same pattern as in nonpregnant patients, with the addition of fetal monitoring. Primary goals of therapy for the mother include rehydration; correction of metabolic acidosis; correction of electrolyte disturbances; blood glucose control; and finding and treating the precipitating cause of the DKA.

Effective management of maternal risk will reduce stress on the fetal environment and improve the chances of fetal preservation. Glucose targets for pregnant patients with diabetes are more aggressive than those for nonpregnant patients TABLE 3.

Once blood glucose is stable within target parameters and the patient is able to tolerate oral intake, the insulin infusion should be titrated off, with overlap of subcutaneous insulin initiation.

Regular human insulin and Neutral Protein Hagedorn NPH insulin have been studied and utilized extensively in pregnancy, and have been found to be safe and effective. Aspart and lispro are also efficacious, safe options for short-acting insulin analogues, when necessary.

Effective management of preeclampsia and DKA can improve maternal and fetal morbidity and mortality. Pharmacists in acute or community settings can help recognize and facilitate the prompt management of these serious conditions in their patients. Leeman L, Fontaine P. Hypertensive disorders of pregnancy.

Am Fam Physician. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. Sibai BM, Barton JR. Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications. Am J Obstet Gynecol. Diagnosis, prevention, and management of eclampsia.

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Schneider MB, Umpierrez GE, Ramsey RD, et al. Pregnancy complicated by diabetic ketoacidosis: maternal and fetal outcomes.

Diabetes Care. Ramin KD. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin North Am. Kamalakannan D, Baskar V, Barton DM, Abdu TA. Postgrad Med J. Tarif N, Al Badr W. Euglycemic diabetic ketoacidosis in pregnancy. Saudi J Kidney Dis Transpl. Metzger BE, Buchanan TA, Coustan DR, et al.

Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus.

Standards of medical care in diabetes Executive summary: standards of medical care in diabetes Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number T32HD The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. contributed to the study concept and design. contributed to the acquisition of data.

contributed to the analysis and interpretation of data. drafted the manuscript. and M. contributed to the statistical analysis. supervised the study. All authors contributed to the critical revision of the manuscript for important intellectual content. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Prior Presentation. Parts of this study were presented in abstract form at the 77th Scientific Sessions of the American Diabetes Association, San Diego, CA, 9—13 June Sign In or Create an Account.

Search Dropdown Menu. header search search input Search input auto suggest. filter your search All Content All Journals Diabetes Care. Advanced Search. User Tools Dropdown. Sign In. Skip Nav Destination Close navigation menu Article navigation. Volume 40, Issue 7. Previous Article Next Article.

Article Information. Article Navigation. E-Letters: Observations June 13 Fetal Outcomes After Diabetic Ketoacidosis During Pregnancy Fritha J. Morrison ; Fritha J. This Site.

Google Scholar. Maryam Movassaghian Maryam Movassaghian. Ellen W. Seely ; Ellen W. Ashley Curran ; Ashley Curran. Maria Shubina ; Maria Shubina. Emma Morton-Eggleston ; Emma Morton-Eggleston. Chloe A. Zera ; Chloe A. Jeffrey L. Ecker ; Jeffrey L. Florence M. Brown ; Florence M.

Alexander Turchin Alexander Turchin. Corresponding author: Alexander Turchin, aturchin bwh.

Diabetic ketoacidosis DKA during pregnancy DKA in gestational diabetes a serious complication gestationaal both mother Natural vitamin resources fetus. Most incidences occur during late pregnancy in women gestatoonal type 1 Weight control forums mellitus. We diabeets DKA in gestational diabetes rare case of a woman with type 1 diabetes mellitus who had normal glucose tolerance during the first trimester but developed DKA during late pregnancy. Although she had initially tested positive for screening of gestational diabetes mellitus during the first trimester, subsequent diagnostic g oral glucose tolerance tests showed normal glucose tolerance. She developed DKA with severe general fatigue in late pregnancy. The patient's general condition improved after treatment for ketoacidosis, and she vaginally delivered a healthy infant at term.

Author: Groktilar

4 thoughts on “DKA in gestational diabetes

  1. Ich entschuldige mich, aber meiner Meinung nach sind Sie nicht recht. Geben Sie wir werden besprechen.

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com